Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Journey of Understanding: How Seeq Empowers Insights & Analytics January 16, 2018 GE Energy Financial Services to invest $90 million in RattanIndia’s solar power assets June 29, 2017 High Accuracy Automation for Aerospace Manufacturing June 17, 2019